Titan Bio-Tech (TITANBIO) | Stock Overview & Key Data
Titan Bio-Tech Performance Comparison
Stock Range
Today's Range
Low: ₹426.70
High: ₹464.00
on August 8, 2025
52 Week Range
Low: ₹373.65
High: ₹1,017.85
on June 19, 2025
on October 21, 2024
All-Time High: ₹1,017.85 on October 21, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR3.9B
EPS
26.08
P/E Ratio (TTM)
18.01
Forward P/E
N/A
P/B Ratio
2.53
PEG Ratio
N/A
Div. Yield
0.47%
ROE
15.01%
Beta
0.324
Debt to Equity
1.82
Financial Highlights
Profitability
Gross Margin
57.31%
Operating Margin
10.60%
Profit Margin
13.76%
Returns and Earnings
Return on Assets (TTM)
8.02%
Return on Equity (TTM)
15.01%
EBITDA
INR293.4M
Net Income (TTM)
INR215.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR189.32
Quarterly Revenue Growth (YoY)
-11.90%
Quarterly Earnings Growth (YoY)
-19.00%
Dividend Information
Last 12-Month Dividend
₹2.00
Current Dividend Yield
0.47%
3-Year Average Dividend Yield
0.45%
3-Year Average Annual Dividend
₹1.77
3-Year Total Dividends
₹5.30
Ex-Dividend Date
September 23, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Titan Bio-Tech TITANBIO | 3.88B Small-cap | 4.49% | -3.34% | 0.20% | -38.24% | -42.03% | -27.01% | 89.08% | 205.28% |
| Biocon BIOCON | 486.32B Large-cap | -10.79% | -7.47% | 2.14% | -9.39% | -7.33% | 8.09% | 17.05% | -7.82% |
| OneSource Specialty ONESOURCE | 217.07B Large-cap | 1.94% | -5.48% | 18.19% | 22.64% | 10.61% | 10.61% | 10.61% | 10.61% |
| Dishman Carbogen DCAL | 37.57B Small-cap | -3.47% | -8.84% | 27.79% | -2.26% | -17.23% | 22.14% | 106.15% | 27.13% |
| Zota Health Care ZOTA | 31.48B Small-cap | -0.78% | -2.36% | 45.12% | 25.14% | 50.88% | 85.82% | 335.52% | 755.41% |
| Panacea Biotec PANACEABIO | 25.23B Small-cap | 2.01% | 1.32% | -18.83% | 4.32% | -6.84% | 204.85% | 215.33% | 148.03% |
Ownership & Short Interest
Insider Ownership
66.73%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
5K
Average 90-Day Volume
7K
Titan Bio-Tech Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Titan Bio-Tech would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TITANBIO's 52-week high and low?
- In the last 52 weeks, Titan Bio-Tech reached a high of ₹1,017.85 (on October 21, 2024) and a low of ₹373.65 (on June 19, 2025).
- What is the market cap and P/E ratio for TITANBIO?
- Curious about Titan Bio-Tech's size and valuation? Its market capitalization stands at 3.88B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.01, and the forward P/E (looking ahead) is N/A.
- Does TITANBIO pay dividends? If so, what's the yield?
- Yes, Titan Bio-Tech is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.47%, and the company has paid an average of ₹1.77 per share annually over the past 3 years.
- Who are Titan Bio-Tech's main competitors or similar companies to consider before investing?
When looking at Titan Bio-Tech, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON486.32B Healthcare Biotechnology 8.09% 17.05% OneSource Specialty
ONESOURCE217.07B Healthcare Biotechnology 10.61% 10.61% Dishman Carbogen
DCAL37.57B Healthcare Biotechnology 22.14% 106.15% Zota Health Care
ZOTA31.48B Healthcare Biotechnology 85.82% 335.52% Panacea Biotec
PANACEABIO25.23B Healthcare Biotechnology 204.85% 215.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Titan Bio-Tech Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Titan Bio-Tech's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.01%, the Debt to Equity ratio from the most recent quarter is 1.82, and its Gross Profit Margin stands at 57.31%.
- What is the recent revenue and earnings growth for TITANBIO?
- Looking at Titan Bio-Tech's growth, its revenue over the trailing twelve months (TTM) was INR2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -11.90%, and quarterly earnings saw a YoY growth of -19.00%.
- How much of TITANBIO stock is held by insiders and institutions?
- Wondering who owns Titan Bio-Tech stock? Company insiders (like executives and directors) hold about 66.73% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.